ALTAGRACE SAINT PAUL-LAFORTUNE: Open Payments
NPI 1558956144 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 65 payments from 17 companies in 2025. Trend: 2023 $151 · 2024 $2,102 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $311 |
| Amgen Inc. | 9 | $142 |
| SCPHARMACEUTICALS INC. | 5 | $135 |
| PFIZER INC. | 5 | $97 |
| Edwards Lifesciences Corporation | 3 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| Novo Nordisk Inc | 3 | $71 |
| GlaxoSmithKline, LLC. | 2 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
Products named: LEQVIO, REPATHA, FUROSCIX, ELIQUIS, SAPIEN 3 Ultra RESILIA, Kerendia, VERQUVO, SHINGRIX.
Industry payments across NY — which companies pay providers there.
